Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children

Journal of Infectious Diseases

Volumn 213, Issue 6, 2016, Pages 985-991

  Reynaldi, Arnold ^a   Schlub, Timothy E ^b   Chelimo, Kiprotich ^c   Sumba, Peter Odada ^c   Piriou, Erwan ^d   Ogolla, Sidney ^c   Moormann, Ann M ^e   Rochford, Rosemary ^d   Davenport, Miles P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Burkitt lymphoma; chronic infection; co infection; Epstein Barr virus; infection dynamics; P. falciparum malaria

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD; BURKITT LYMPHOMA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; HUMAN; INFANT; KENYAN; LONGITUDINAL STUDY; MALARIA FALCIPARUM; MIXED INFECTION; PRIORITY JOURNAL; VIROGENESIS; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION; AREA UNDER THE CURVE; COMPLICATION; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; KENYA; MALARIA, FALCIPARUM; NEWBORN; PHYSIOLOGY; PLASMODIUM FALCIPARUM; PROPORTIONAL HAZARDS MODEL; VIROLOGY; VIRUS REPLICATION;

AREA UNDER CURVE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROPORTIONAL HAZARDS MODELS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84964799427     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv525     Document Type: Article

References (20)

1. Burkitt DP. The discovery of Burkitt's lymphoma. Cancer 1983; 51:1777-86.
2. Morrow RH, Gutensohn N, Smith PG. Epstein-Barr virus-malaria interaction models for Burkitt's lymphoma: implications for preventive trials. Cancer Res 1976; 36:667-9.
3. Facer CA, Playfair JH. Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res 1989; 53:33-72.
4. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1978; 22:239-43.
5. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005; 191:1233-8.
6. Piriou E, Asito AS, Sumba PO, et al. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 2012; 205:906-13.
7. Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol 2013; 3:227-32.
8. Njie R, Bell AI, Jia H, et al. The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 2009; 199:31-8.
9. Lam KM, Syed N, Whittle H, Crawford DH. Circulating Epstein-Barr viruscarrying B cells in acute malaria. Lancet 1991; 337:876-8.
10. Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 2005; 61:461-5.
11. Piriou E, Kimmel R, Chelimo K, et al. Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol 2009; 81:1088-93.
12. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol 2005; 3:182-7.
13. de-The G. Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1977; 1:335-8.
14. Mulama DH, Bailey JA, Foley J, et al. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer 2014; 134:645-53.
15. Cromer D, Tey SK, Khanna R, Davenport MP. Estimating cytomegalovirus growth rates by using only a single point. J Virol 2013; 87:3376-81.
16. Bitan M, Or R, Shapira MY, et al. Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin Infect Dis 2004; 39:1076-8.
17. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 2008; 111:1420-7.
18. Inazawa N, Hori T, Hatakeyama N, et al. Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation. J Med Virol 2015; 87:1427-35.
19. Chiusolo P, Metafuni E, Cattani P, et al. Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. J Clin Immunol 2010; 30:894-902.
20. Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA. A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis. PLoS Pathog 2014; 10:e1004170.